Pacific Sage Partners’s Eli Lilly LLY Stock Holding History

Pacific Sage Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4M	Buy	1,524 +208	+16%	+$211K	0.22%	45
2025 Q4	$1.41M	Sell	1,316 -56	-4%	-$53.5K	0.22%	42
2025 Q3	$1.05M	Sell	1,372 -2	-0.1%	-$1.49K	0.18%	46
2025 Q2	$1.07M	Sell	1,374 -23	-2%	-$17.9K	0.21%	45
2025 Q1	$1.15M	Hold	1,397	–	–	0.26%	43
2024 Q4	$1.08M	Hold	1,397	–	–	0.25%	41
2024 Q3	$1.24M	Hold	1,397	–	–	0.29%	37
2024 Q2	$1.26M	Buy	1,397 +6	+0.4%	+$4.8K	0.31%	35
2024 Q1	$1.08M	Sell	1,391 -100	-7%	-$71.2K	0.28%	39
2023 Q4	$869K	Sell	1,491 -100	-6%	-$58.4K	0.24%	41
2023 Q3	$855K	Hold	1,591	–	–	0.26%	39
2023 Q2	$746K	Buy	1,591 +22	+1%	+$9.23K	0.22%	38
2023 Q1	$539K	Hold	1,569	–	–	0.17%	42
2022 Q4	$574K	Buy	+1,569	New	+$556K	0.19%	41

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pacific Sage Partners's LLY Position: Q1 2026 in Review

Pacific Sage Partners increased its Eli Lilly (LLY) stake by 16% in Q1 2026, buying an estimated $211K and bringing the position to 1,524 shares worth $1.4M. The position accounts for 0.22% of the portfolio, ranked #45.

Pacific Sage Partners first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.41M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Pacific Sage Partners held 1,524 shares of Eli Lilly worth $1.4M as of Q1 2026.
Pacific Sage Partners bought 208 Eli Lilly shares in Q1 2026, an estimated $211K.
Eli Lilly made up 0.22% of Pacific Sage Partners's portfolio in Q1 2026, its #45 holding.
Pacific Sage Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Pacific Sage Partners's Eli Lilly position peaked at $1.41M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pacific Sage Partners's 13F filing for Q1 2026, filed 21 Apr 2026.